Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search

Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

Profile Photo

Dr. Martin Barr

Clinical Senior Lecturer (Clinical Medicine)


Clinical Senior Lecturer (Molecular Medicine Ireland)

  Anticancer therapies   Apoptosis and cancer   Biomarkers   Cancer Biology   Cancer chemotherapeutic drugs- mode of action   Cancer genetics and cell biology including metastasis   Cancer Stemness   CANCER-CELLS   Drug repurposing   Liquid Biopsy   Lung Cancer   Non-small cell lung cancer
Language Skill Reading Skill Writing Skill Speaking
English Fluent Fluent Fluent
French Medium Medium Medium
Irish Medium Medium Basic
Details Date From Date To
Member of the Irish Association for Cancer Research (IACR).
Member & Ambassador of the European Association for Cancer Research (EACR).
Member of the International Association for the Study of Lung Cancer (IASLC).
Member (Associate) of the European Society for Medical Oncology (ESMO).
Member of the Irish Thoracic Society (ITS).
Member of the European Respiratory Society (ERS).
Fellow of the Institute of Biomedical Science UK (IBMS).
Chartered Scientist (Science Council, UK).
Member of the Irish Platform for Patients' Organisations, Science and Industry (IPPOSI).
Member of the Health Research Board-Clinical Research Coordination Ireland (HRB-CRCI).
Member of the Academy of Clinical Science & Laboratory Medicine (ACSLM).
Member of Clinical Trials Ireland (CTI).
Member of Council of the Irish Association of Clinical Scientists (IACS).
Member of the National Standards Authority of Ireland (NSAI)- National Mirror Committee for Biobanking Standards in Ireland (ISO 20387).
Irish Lung Cancer Alliance (ILCA).
MacDonagh L, Gray SG, Breen E, Cuffe S, Finn SP, O'Byrne KJ, Barr MP, Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin., Translational Oncology, 14, (4), 2021, p101025-, Journal Article, PUBLISHED
MacDonagh L, Gallagher MF, Ffrench B, Gasch C, Gray SG, Reidy M, Nicholson S, Leonard N, Ryan R, Young V, O'Leary JJ, Cuffe S, Finn SP, O'Byrne KJ, Barr MP., MicroRNA expression profiling and biomarker validation in treatment-na├»ve and drug resistant non-small cell lung cancer., Translational lung cancer research, 10, (4), 2021, p1773-1791 , Journal Article, PUBLISHED  DOI
Flynn L*, Barr MP*, Baird AM*, Smyth P, Casey OM, Blackshields G, Greene J, Pennington SR, Hams E, Fallon PG, O'Leary JJ, Sheils O, Finn SP. , Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness., Scientific Reports, 10, (1), 2020, p11329-, Journal Article, PUBLISHED
Hu L, Shen D, Liang D, Shi J, Song C, Jiang K, Menglin Ren, Du S, Cheng W, Ma J, Li S, Bi X, Barr MP, Fang Z, Xu Q, Li W, Piao H, Meng S., Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth., Cancer Letters, 493, 2020, p156 - 166, Journal Article, PUBLISHED
Thunnissen E, Kerr KM, Dafni U, Bubendorf L, Finn SP, Soltermann A, Biernat W, Cheney R, Verbeken E, Warth A, Marchetti A, Speel EM, Pokharel S, Quinn AM, Monkhorst K, Navarro A, Madsen LB, Tsourti Z, Geiger T, Kammler R, Peters S, Stahel RA; European Thoracic Oncology Platform Lungscape Consortium., Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort., Modern Pathology, 33, (5), 2020, p792 - 801, Journal Article, PUBLISHED
Martin P. Barr, Patient-oriented Biobanking for Cancer Research, Cancer Studies & Therapeutics, 4, (3), 2019, p1 - 2, Journal Article, PUBLISHED
Baird AM, Easty D, Jarzabek M, Shiels L, Soltermann A, Klebe S, Raeppel S, MacDonagh L, Wu C, Griggs K, Kirschner MB, Stanfill B, Nonaka D, Goparaju CM, Murer B, Fennell DA, O'Donnell DM, Barr MP, Mutti L, Reid G, Finn S, Cuffe S, Pass HI, Opitz I, Byrne AT, O'Byrne KJ, Gray SG., When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?, Frontiers in endocrinology, 10, 2019, p89 , Journal Article, PUBLISHED  DOI
Ryan, S.-L. and Beard, S. and Barr, M.P. and Umezawa, K. and Heavey, S. and Godwin, P. and Gray, S.G. and Cormican, D. and Finn, S.P. and Gately, K.A. and Davies, A.M. and Thompson, E.W. and Richard, D.J. and O'Byrne, K.J. and Adams, M.N. and Baird, A.-M., Targeting NF-KB-mediated inflammatory pathways in cisplatin-resistant NSCLC, Lung Cancer, 135, 2019, p217-227 , Notes: [cited By 0], Journal Article, PUBLISHED  DOI
Heavey S, Dowling P, Moore G, Barr MP, Kelly N, Maher SG, Cuffe S, Finn SP, O'Byrne KJ, Gately K., Development and characterisation of a panel of phosphatidylinositide 3-kinase - mammalian target of rapamycin inhibitor resistant lung cancer cell lines., Scientific Reports, 8, (1), 2018, p1652-, Journal Article, PUBLISHED  TARA - Full Text  DOI
MacDonagh, L. and Gray, S.G. and Breen, E. and Cuffe, S. and Finn, S.P. and O'Byrne, K.J. and Barr, M.P., BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC, Cancer Letters, 428, 2018, p117-126 , Notes: [cited By 0], Journal Article, PUBLISHED  DOI

Page 1 of 5
Martin P. Barr, Lung Cancer Screening: is Ireland ready?, 7, 2, Medical Independent, Medical Independent, July, 2021, p20 - 22, Report, PUBLISHED